Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT00536016
A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2007
Completion: Dec 31, 2009